Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Minoru Tobiume

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Nature Biomedical Engineering|April 6, 2019
A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaquesKeiichi Yamaguchi, Yuji O Kamatari, Fumiko Ono, et al.
Japanese Journal of Infectious Diseases|January 23, 2010
The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examinationNoriko Nakajima, Satoru Hata, Yuko Sato, et al.
Vaccine|September 5, 2022
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathologyTakuya Hemmi, Akira Ainai, Takao Hashiguchi, et al.
Plos One|September 19, 2023
Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccinationToshihiro Takahashi, Tomohiko Ai, Kaori Saito, et al.
Emerging Infectious Diseases|March 15, 2022
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected VaccineesKenichiro Takahashi, Masahiro Ishikane, Mugen Ujiie, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2023
Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19Tadashi Hosoya, Seiya Oba, Yoji Komiya, et al.
Scientific Reports|September 1, 2022
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodiesMaika Takahashi, Tomohiko Ai, Konomi Sinozuka, et al.
Emerging Infectious Diseases|April 11, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020Yuzo Arima, Tomoe Shimada, Motoi Suzuki, et al.
Scientific Reports|October 30, 2024
Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipidsTetsuya Kuwano, Takayuki Kanno, Minoru Tobiume, et al.
Immunity|July 11, 2021
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variantsSaya Moriyama, Yu Adachi, Takashi Sato, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Nature Biomedical Engineering|April 6, 2019
A designer molecular chaperone against transmissible spongiform encephalopathy slows disease progression in mice and macaquesKeiichi Yamaguchi, Yuji O Kamatari, Fumiko Ono, et al.
Japanese Journal of Infectious Diseases|January 23, 2010
The first autopsy case of pandemic influenza (A/H1N1pdm) virus infection in Japan: detection of a high copy number of the virus in type II alveolar epithelial cells by pathological and virological examinationNoriko Nakajima, Satoru Hata, Yuko Sato, et al.
Vaccine|September 5, 2022
Intranasal vaccination induced cross-protective secretory IgA antibodies against SARS-CoV-2 variants with reducing the potential risk of lung eosinophilic immunopathologyTakuya Hemmi, Akira Ainai, Takao Hashiguchi, et al.
Plos One|September 19, 2023
Assessment of antibody dynamics and neutralizing activity using serological assay after SARS-CoV-2 infection and vaccinationToshihiro Takahashi, Tomohiko Ai, Kaori Saito, et al.
Emerging Infectious Diseases|March 15, 2022
Duration of Infectious Virus Shedding by SARS-CoV-2 Omicron Variant-Infected VaccineesKenichiro Takahashi, Masahiro Ishikane, Mugen Ujiie, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 22, 2023
Apple-shaped obesity: A risky soil for cytokine-accelerated severity in COVID-19Tadashi Hosoya, Seiya Oba, Yoji Komiya, et al.
Scientific Reports|September 1, 2022
Activation of SARS-CoV-2 neutralizing antibody is slower than elevation of spike-specific IgG, IgM, and nucleocapsid-specific IgG antibodiesMaika Takahashi, Tomohiko Ai, Konomi Sinozuka, et al.
Emerging Infectious Diseases|April 11, 2020
Severe Acute Respiratory Syndrome Coronavirus 2 Infection among Returnees to Japan from Wuhan, China, 2020Yuzo Arima, Tomoe Shimada, Motoi Suzuki, et al.
Scientific Reports|October 30, 2024
Non-invasive SARS-CoV-2 RNA detection and human transcriptome analysis using skin surface lipidsTetsuya Kuwano, Takayuki Kanno, Minoru Tobiume, et al.
Immunity|July 11, 2021
Temporal maturation of neutralizing antibodies in COVID-19 convalescent individuals improves potency and breadth to circulating SARS-CoV-2 variantsSaya Moriyama, Yu Adachi, Takashi Sato, et al.
Pageof 6